How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature

References

• Ostrom QT, Price M, Neff C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro Oncol. 2022;24(Suppl 5). doi:10.1093/neuonc/noac202
   Google Scholar
• Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842–1850. doi:10.1001/jama.2013.280319
   PubMed Web of Science ®Google Scholar
• Paw I, Carpenter RC, Watabe K, Debinski W, Lo H-W. Mechanisms regulating glioma invasion. Cancer Lett. 2015;362(1):1–7. doi:10.1016/j.canlet.2015.03.015
   PubMed Web of Science ®Google Scholar
• Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994;34(1):45–60; discussion 60–1. doi:10.1097/00006123-199401000-00008
   Web of Science ®Google Scholar
• Koo Y-EL, Reddy GR, Bhojani M, et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev. 2006;58(14):1556–1577. doi:10.1016/j.addr.2006.09.012
   PubMed Web of Science ®Google Scholar
• Ji B, Wei M, Yang B. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics. 2022;12(1):434–458. doi:10.7150/thno.67300
   PubMed Web of Science ®Google Scholar
• Lu L, Wang K, Lin C, et al. Constructing nanocomplexes by multicomponent self-assembly for curing orthotopic glioblastoma with synergistic chemo-photothermal therapy. Biomaterials. 2021;279:121193. doi:10.1016/j.biomaterials.2021.121193
   PubMed Web of Science ®Google Scholar
• Bunevicius A, Pikis S, Padilla F, Prada F, Sheehan J. Sonodynamic therapy for gliomas. J Neurooncol. 2022;156(1):1–10. doi:10.1007/s11060-021-03807-6
   PubMed Web of Science ®Google Scholar
• Li C, Wan Y, Zhang Y, et al. In situ sprayed starvation/chemodynamic therapeutic gel for post-surgical treatment of IDH1 (R132H) glioma. Adv Mater. 2022;34(5):e2103980. doi:10.1002/adma.202103980
   PubMed Web of Science ®Google Scholar
• Tamura R, Miyoshi H, Yoshida K, Okano H, Toda M. Recent progress in the research of suicide gene therapy for malignant glioma. Neurosurg Rev. 2021;44(1):29–49. doi:10.1007/s10143-019-01203-3
   PubMed Web of Science ®Google Scholar
• Hosseini R, Sarvnaz H, Arabpour M, et al. Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. Mol Cancer. 2022;21(1):15. doi:10.1186/s12943-021-01492-7
   PubMed Web of Science ®Google Scholar
• Dong X. Current strategies for brain drug delivery. Theranostics. 2018;8(6):1481–1493. doi:10.7150/thno.21254
   PubMed Web of Science ®Google Scholar
• Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov. 2021;20(5):362–383. doi:10.1038/s41573-021-00139-y
   PubMed Web of Science ®Google Scholar
• Yang K, Wu Z, Zhang H, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21(1):39. doi:10.1186/s12943-022-01513-z
   PubMed Web of Science ®Google Scholar
• Maeda H. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev. 2001;46(1–3):169–185. doi:10.1016/S0169-409X(00)00134-4
   PubMed Web of Science ®Google Scholar
• Wang J, Li Y, Nie G. Multifunctional biomolecule nanostructures for cancer therapy. Nat Rev Mater. 2021;6(9):766–783. doi:10.1038/s41578-021-00315-x
   PubMed Web of Science ®Google Scholar
• Quader S, Kataoka K. Nanomaterial-enabled cancer therapy. Mol Ther. 2017;25(7):1501–1513. doi:10.1016/j.ymthe.2017.04.026
   PubMed Web of Science ®Google Scholar
• Tsoi KM, MacParland SA, X-z M, et al. Mechanism of hard-nanomaterial clearance by the liver. Nat Mater. 2016;15(11):1212–1221. doi:10.1038/nmat4718
   PubMed Web of Science ®Google Scholar
• Fan Z, Zhu P, Zhu Y, Wu K, Li CY, Cheng H. Engineering long-circulating nanomaterial delivery systems. Curr Opin Biotechnol. 2020;66:131–139. doi:10.1016/j.copbio.2020.07.006
   PubMed Web of Science ®Google Scholar
• Chen L, Hong W, Ren W, Xu T, Qian Z, He Z. Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduct Target Ther. 2021;6(1):225. doi:10.1038/s41392-021-00631-2
   PubMed Web of Science ®Google Scholar
• Attarilar S, Yang J, Ebrahimi M, et al. The toxicity phenomenon and the related occurrence in metal and metal oxide nanoparticles: a brief review from the biomedical perspective. Front Bioeng Biotechnol. 2020;8:822. doi:10.3389/fbioe.2020.00822
   PubMed Web of Science ®Google Scholar
• Yang Q, Lai SK. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015;7(5):655–677. doi:10.1002/wnan.1339
   PubMed Web of Science ®Google Scholar
• Tang W, Fan W, Lau J, Deng L, Shen Z, Chen X. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev. 2019;48(11):2967–3014. doi:10.1039/c8cs00805a
   PubMed Web of Science ®Google Scholar
• Pehlivan SB. Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases. Pharm Res. 2013;30(10):2499–2511. doi:10.1007/s11095-013-1156-7
   PubMed Web of Science ®Google Scholar
• Li B, Wang F, Gui L, He Q, Yao Y, Chen H. The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Nanomedicine. 2018;13(16):2099–2118. doi:10.2217/nnm-2018-0017
   PubMed Web of Science ®Google Scholar
• Menilli L, Milani C, Reddi E, Moret F. Overview of nanoparticle-based approaches for the combination of Photodynamic Therapy (PDT) and chemotherapy at the preclinical stage. Cancers. 2022;14(18):4462. doi:10.3390/cancers14184462
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo J, Chen X, Liu W, Chen T. Cell membrane coating technology: a promising strategy for biomedical applications. Nanomicro Lett. 2019;11(1). doi:10.1007/s40820-019-0330-9
   Web of Science ®Google Scholar
• Luk BT, Zhang L. Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release. 2015;220(Pt B):600–607. doi:10.1016/j.jconrel.2015.07.019
   PubMed Web of Science ®Google Scholar
• Parayath NN, Amiji MM. Therapeutic targeting strategies using endogenous cells and proteins. J Control Release. 2017;258:81–94. doi:10.1016/j.jconrel.2017.05.004
   PubMed Web of Science ®Google Scholar
• Neumann E, Frei E, Funk D, et al. Native albumin for targeted drug delivery. Expert Opin Drug Deliv. 2010;7(8):915–925. doi:10.1517/17425247.2010.498474
   PubMed Web of Science ®Google Scholar
• Jia Y, Sheng Z, Hu D, et al. Highly penetrative liposome nanomedicine generated by a biomimetic strategy for enhanced cancer chemotherapy. Biomater Sci. 2018;6(6):1546–1555. doi:10.1039/c8bm00256h
   PubMed Web of Science ®Google Scholar
• Zhuang D, Zhang H, Hu G, Guo B. Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma. J Nanobiotechnology. 2022;20(1):284. doi:10.1186/s12951-022-01479-6
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 2011;108(27):10980–10985. doi:10.1073/pnas.1106634108
   PubMed Web of Science ®Google Scholar
• Men X, Geng X, Zhang Z, et al. Biomimetic semiconducting polymer dots for highly specific NIR-II fluorescence imaging of glioma. Mater Today Bio. 2022;16:100383. doi:10.1016/j.mtbio.2022.100383
   PubMedGoogle Scholar
• Wang Z, Zhang M, Chi S, Zhu M, Wang C, Liu Z. Brain tumor cell membrane-coated lanthanide-doped nanoparticles for NIR-IIb luminescence imaging and surgical navigation of glioma. Adv Healthc Mater. 2022;11(16):e2200521. doi:10.1002/adhm.202200521
   PubMed Web of Science ®Google Scholar
• Zou Y, Wang Y, Xu S, et al. Brain co-delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy. Adv Mater. 2022;34(33):e2203958. doi:10.1002/adma.202203958
   PubMed Web of Science ®Google Scholar
• Fan Y, Hao W, Cui Y, et al. Cancer cell membrane-coated nanosuspensions for enhanced chemotherapeutic treatment of glioma. Molecules. 2021;26(16):5103.
   PubMed Web of Science ®Google Scholar
• Ren Y, Miao C, Tang L, et al. Homotypic cancer cell membranes camouflaged nanoparticles for targeting drug delivery and enhanced chemo-photothermal therapy of glioma. Pharmaceuticals. 2022;15(2):157. doi:10.3390/ph15020157
   Web of Science ®Google Scholar
• Zhu M, Wu P, Li Y, Zhang L, Zong Y, Wan M. Synergistic therapy for orthotopic gliomas biomimetic nanosonosensitizer-mediated sonodynamic therapy and ferroptosis. Biomater Sci. 2022;10(14):3911–3923. doi:10.1039/d2bm00562j
   PubMed Web of Science ®Google Scholar
• Liu G, Zhu J, Guo H, et al. Mo2C-derived polyoxometalate for NIR-II photoacoustic imaging-guided chemodynamic/photothermal synergistic therapy. Angew Chem Int Ed. 2019;58(51):18641–18646. doi:10.1002/anie.201910815
   PubMed Web of Science ®Google Scholar
• Du J, Sun J, Liu X, et al. Preparation of C6 cell membrane-coated doxorubicin conjugated manganese dioxide nanoparticles and its targeted therapy application in glioma. Eur J Pharm Sci. 2022;180:106338. doi:10.1016/j.ejps.2022.106338
   PubMed Web of Science ®Google Scholar
• Lu G, Wang X, Li F, et al. Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma. Nat Commun. 2022;13(1):4214. doi:10.1038/s41467-022-31799-y
   PubMed Web of Science ®Google Scholar
• Huang X, Hui H, Shang W, et al. Deep penetrating and sensitive targeted magnetic particle imaging and photothermal therapy of early-stage glioblastoma based on a biomimetic nanoplatform. Adv Sci. 2023:e2300854. doi:10.1002/advs.202300854
   Web of Science ®Google Scholar
• Zhao P, Tian Y, Lu Y, et al. Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis. J Nanobiotechnology. 2022;20(1):525. doi:10.1186/s12951-022-01731-z
   PubMed Web of Science ®Google Scholar
• Kong J, Zou R, Law G-L, Wang Y. Biomimetic multifunctional persistent luminescence nanoprobes for long-term near-infrared imaging and therapy of cerebral and cerebellar gliomas. Sci Adv. 2022;8(10):eabm7077. doi:10.1126/sciadv.abm7077
   PubMed Web of Science ®Google Scholar
• Chai Z, Ran D, Lu L, et al. Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma. ACS Nano. 2019;13(5):5591–5601. doi:10.1021/acsnano.9b00661
   PubMed Web of Science ®Google Scholar
• Fu S, Liang M, Wang Y, et al. Dual-modified novel biomimetic nanocarriers improve targeting and therapeutic efficacy in glioma. ACS Appl Mater Interfaces. 2019;11(2):1841–1854. doi:10.1021/acsami.8b18664
   PubMed Web of Science ®Google Scholar
• Zou Y, Liu Y, Yang Z, et al. Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine. Adv Mater. 2018;30(51):e1803717. doi:10.1002/adma.201803717
   PubMed Web of Science ®Google Scholar
• Chai Z, Hu X, Wei X, et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release. 2017;264:102–111. doi:10.1016/j.jconrel.2017.08.027
   PubMed Web of Science ®Google Scholar
• Zhang D, Tian S, Liu Y, et al. Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma. Nat Commun. 2022;13(1):6835. doi:10.1038/s41467-022-34462-8
   PubMed Web of Science ®Google Scholar
• Liu Y, Zou Y, Feng C, et al. Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy. Nano Lett. 2020;20(3):1637–1646. doi:10.1021/acs.nanolett.9b04683
   PubMed Web of Science ®Google Scholar
• Ismail M, Yang W, Li Y, et al. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition. Biomaterials. 2022;289:121760. doi:10.1016/j.biomaterials.2022.121760
   PubMed Web of Science ®Google Scholar
• He W, Li X, Morsch M, et al. Brain-targeted codelivery of Bcl-2/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy. ACS Nano. 2022;16(4):6293–6308. doi:10.1021/acsnano.2c00320
   PubMed Web of Science ®Google Scholar
• Ke R, Zhen X, Wang H-S, et al. Surface functionalized biomimetic bioreactors enable the targeted starvation-chemotherapy to glioma. J Colloid Interface Sci. 2022;609:307–319. doi:10.1016/j.jcis.2021.12.009
   PubMed Web of Science ®Google Scholar
• Pang L, Qin J, Han L, et al. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma. Oncotarget. 2016;7(24):37081–37091. doi:10.18632/oncotarget.9464
   PubMedGoogle Scholar
• Pang L, Zhu Y, Qin J, Zhao W, Wang J. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy. Drug Deliv. 2018;25(1):1922–1931. doi:10.1080/10717544.2018.1502839
   PubMed Web of Science ®Google Scholar
• Wang S, Shen H, Mao Q, et al. Macrophage-mediated porous magnetic nanoparticles for multimodal imaging and postoperative photothermal therapy of gliomas. ACS Appl Mater Interfaces. 2021;13(48):56825–56837. doi:10.1021/acsami.1c12406
   PubMed Web of Science ®Google Scholar
• Xiao T, He M, Xu F, et al. Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy/chemodynamic therapy of orthotopic glioma. ACS Nano. 2021;15(12):20377–20390. doi:10.1021/acsnano.1c08689
   PubMed Web of Science ®Google Scholar
• Yin T, Fan Q, Hu F, et al. Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity. Nano Lett. 2022;22(16):6606–6614. doi:10.1021/acs.nanolett.2c01863
   PubMed Web of Science ®Google Scholar
• Liu B, Ji Q, Cheng Y, et al. Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM. J Nanobiotechnology. 2022;20(1):161. doi:10.1186/s12951-022-01360-6
   PubMed Web of Science ®Google Scholar
• Qiao S, Cheng Y, Liu M, et al. Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme. J Control Release. 2021;336:54–70. doi:10.1016/j.jconrel.2021.06.015
   PubMed Web of Science ®Google Scholar
• Xue J, Zhao Z, Zhang L, et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol. 2017;12(7):692–700. doi:10.1038/nnano.2017.54
   PubMed Web of Science ®Google Scholar
• Deng G, Peng X, Sun Z, et al. Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-II fluorescence-guided glioma theranostics. ACS Nano. 2020;14(9):11452–11462. doi:10.1021/acsnano.0c03824
   PubMed Web of Science ®Google Scholar
• Ma X, Kuang L, Yin Y, et al. Tumor-antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma. ACS Nano. 2023;17(3):2341–2355. doi:10.1021/acsnano.2c09033
   PubMed Web of Science ®Google Scholar
• Geng X, Gao D, Hu D, et al. Active-targeting NIR-II phototheranostics in multiple tumor models using platelet-camouflaged nanoprobes. ACS Appl Mater Interfaces. 2020;12(50):55624–55637. doi:10.1021/acsami.0c16872
   PubMed Web of Science ®Google Scholar
• Wu L, Li Q, Deng J, et al. Platelet-tumor cell hybrid membrane-camouflaged nanoparticles for enhancing therapy efficacy in glioma. Int J Nanomedicine. 2021;16:8433–8446. doi:10.2147/IJN.S333279
   PubMed Web of Science ®Google Scholar
• Hao W, Cui Y, Fan Y, et al. Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery. J Nanobiotechnology. 2021;19(1):378. doi:10.1186/s12951-021-01110-0
   PubMed Web of Science ®Google Scholar
• Jiao X, Yu X, Gong C, et al. Erythrocyte-cancer hybrid membrane-camouflaged mesoporous silica nanoparticles loaded with gboxin for glioma-targeting therapy. Curr Pharm Biotechnol. 2022;23(6):835–846. doi:10.2174/1389201022666210719164538
   PubMed Web of Science ®Google Scholar
• Wang M, C-y L, S-A L, et al. Near infrared light fluorescence imaging-guided biomimetic nanoparticles of extracellular vesicles deliver indocyanine green and paclitaxel for hyperthermia combined with chemotherapy against glioma. J Nanobiotechnology. 2021;19(1):210. doi:10.1186/s12951-021-00907-3
   PubMed Web of Science ®Google Scholar
• J-Y W, Y-J L, X-b H, et al. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: a head-to-head comparison. J Control Release. 2021;336:510–521. doi:10.1016/j.jconrel.2021.07.004
   PubMed Web of Science ®Google Scholar
• J-y W, Y-j L, Wang J, et al. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein Corona. J Nanobiotechnology. 2021;19(1):405. doi:10.1186/s12951-021-01153-3
   PubMed Web of Science ®Google Scholar
• Rehman FU, Liu Y, Yang Q, et al. Heme oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy. J Control Release. 2022;345:696–708. doi:10.1016/j.jconrel.2022.03.036
   PubMed Web of Science ®Google Scholar
• Niu W, Xiao Q, Wang X, et al. A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy. Nano Lett. 2021;21(3):1484–1492. doi:10.1021/acs.nanolett.0c04753
   PubMed Web of Science ®Google Scholar
• Santos-Coquillat A, Herreros-Pérez D, Samaniego R, et al. Dual-labeled nanoparticles based on small extracellular vesicles for tumor detection. Biol Direct. 2022;17(1):31. doi:10.1186/s13062-022-00345-7
   PubMed Web of Science ®Google Scholar
• Liang S-F, Zuo -F-F, Yin B-C, Ye B-C. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3. Biomater Sci. 2022;10(6):1582–1590. doi:10.1039/d1bm01723c
   PubMed Web of Science ®Google Scholar
• Pietras A, Katz AM, Ekström EJ, et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell. 2014;14(3):357–369. doi:10.1016/j.stem.2014.01.005
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao P, Luo Z, et al. Cancer cell membrane–biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano. 2016;10(11):10049–10057. doi:10.1021/acsnano.6b04695
   PubMed Web of Science ®Google Scholar
• Wang H, Liu Y, He R, et al. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery. Biomater Sci. 2020;8(2):552–568. doi:10.1039/c9bm01392j
   PubMed Web of Science ®Google Scholar
• Rao L, L-L B, Cai B, et al. Cancer cell membrane-coated upconversion nanoprobes for highly specific tumor imaging. Adv Mater. 2016;28(18):3460–3466. doi:10.1002/adma.201506086
   PubMed Web of Science ®Google Scholar
• Dale GL, Kuhl W, Beutler E. Incorporation of glucocerebrosidase into gaucher’s disease monocytes in vitro. Proc Natl Acad Sci. 1979;76(1):473–475. doi:10.1073/pnas.76.1.473
   PubMed Web of Science ®Google Scholar
• Sun Y, Su J, Liu G, et al. Advances of blood cell-based drug delivery systems. Eur J Pharm Sci. 2017;96:115–128. doi:10.1016/j.ejps.2016.07.021
   PubMed Web of Science ®Google Scholar
• Pierigè F, Serafini S, Rossi L, Magnani M. Cell-based drug delivery. Adv Drug Deliv Rev. 2008;60(2):286–295. doi:10.1016/j.addr.2007.08.029
   PubMed Web of Science ®Google Scholar
• Javed S, Alshehri S, Shoaib A, et al. Chronicles of nanoerythrosomes: an erythrocyte-based biomimetic smart drug delivery system as a therapeutic and diagnostic tool in cancer therapy. Pharmaceutics. 2021;13(3):368. doi:10.3390/pharmaceutics13030368
   PubMed Web of Science ®Google Scholar
• Mohale S, Kunde SS, Wairkar S. Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy. Colloids Surf B Biointerfaces. 2022;219:112803. doi:10.1016/j.colsurfb.2022.112803
   PubMed Web of Science ®Google Scholar
• Fukuta T, Yoshimi S, Tanaka T, Kogure K. Leukocyte-mimetic liposomes possessing leukocyte membrane proteins pass through inflamed endothelial cell layer by regulating intercellular junctions. Int J Pharm. 2019;563:314–323. doi:10.1016/j.ijpharm.2019.04.027
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545. doi:10.1016/S0140-6736(00)04046-0
   PubMed Web of Science ®Google Scholar
• Brynskikh AM, Zhao Y, Mosley RL, et al. Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson’s disease. Nanomedicine. 2010;5(3):379–396. doi:10.2217/nnm.10.7
   PubMed Web of Science ®Google Scholar
• Jinushi M, Komohara Y. Tumor-associated macrophages as an emerging target against tumors: creating a new path from bench to bedside. Biochim Biophys Acta. 2015;1855(2):123–130. doi:10.1016/j.bbcan.2015.01.002
   PubMed Web of Science ®Google Scholar
• Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci. 2016;19(1):20–27. doi:10.1038/nn.4185
   PubMed Web of Science ®Google Scholar
• Gutmann DH, Kettenmann H. Microglia/brain macrophages as central drivers of brain tumor pathobiology. Neuron. 2019;104(3):442–449. doi:10.1016/j.neuron.2019.08.028
   PubMed Web of Science ®Google Scholar
• Green LA, Nebiolo JC, Smith CJ, Eroglu C. Microglia exit the CNS in spinal root avulsion. PLoS Biol. 2019;17(2):e3000159. doi:10.1371/journal.pbio.3000159
   PubMed Web of Science ®Google Scholar
• Guo X, Pan Y, Gutmann DH. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia. Neuro Oncol. 2019;21(10):1250–1262. doi:10.1093/neuonc/noz080
   PubMed Web of Science ®Google Scholar
• Feng L, Dou C, Xia Y, et al. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery. ACS Nano. 2021;15(2):2263–2280. doi:10.1021/acsnano.0c07973
   PubMed Web of Science ®Google Scholar
• Joice SL, Mydeen F, Couraud P-O, et al. Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies. Brain Res. 2009;1298:13–23. doi:10.1016/j.brainres.2009.08.076
   PubMed Web of Science ®Google Scholar
• Guillerey C, Huntington ND, Smyth MJ. Targeting natural killer cells in cancer immunotherapy. Nat Immunol. 2016;17(9):1025–1036. doi:10.1038/ni.3518
   PubMed Web of Science ®Google Scholar
• Chiossone L, Dumas P-Y, Vienne M, Vivier E. Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol. 2018;18(11):671–688. doi:10.1038/s41577-018-0061-z
   PubMed Web of Science ®Google Scholar
• Lu Y, Hu Q, Jiang C, Gu Z. Platelet for drug delivery. Curr Opin Biotechnol. 2019;58:81–91. doi:10.1016/j.copbio.2018.11.010
   PubMed Web of Science ®Google Scholar
• Chen Z, Hu Q, Gu Z. Leveraging engineering of cells for drug delivery. Acc Chem Res. 2018;51(3):668–677. doi:10.1021/acs.accounts.7b00526
   PubMed Web of Science ®Google Scholar
• C-mj H, Fang RH, Wang K-C, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118–121. doi:10.1038/nature15373
   PubMed Web of Science ®Google Scholar
• Zeng Z, Pu K. Improving cancer immunotherapy by cell membrane‐camouflaged nanoparticles. Adv Funct Mater. 2020;30(43):2004397. doi:10.1002/adfm.202004397
   Web of Science ®Google Scholar
• Jin J, Bhujwalla ZM. Biomimetic nanoparticles camouflaged in cancer cell membranes and their applications in cancer theranostics. Perspective. Front Oncol. 2020;9. doi:10.3389/fonc.2019.01560
   Web of Science ®Google Scholar
• Xia Q, Zhang Y, Li Z, Hou X, Feng N. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B. 2019;9(4):675–689. doi:10.1016/j.apsb.2019.01.011
   PubMed Web of Science ®Google Scholar
• Kunde SS, Wairkar S. Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy. Int J Pharm. 2021;598:120395. doi:10.1016/j.ijpharm.2021.120395
   PubMed Web of Science ®Google Scholar
• Wang Y, Luan Z, Zhao C, Bai C, Yang K. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy. Eur J Pharm Sci. 2020;142:105136. doi:10.1016/j.ejps.2019.105136
   PubMed Web of Science ®Google Scholar
• de Jong OG, Kooijmans SAA, Murphy DE, et al. Drug delivery with extracellular vesicles: from imagination to innovation. Acc Chem Res. 2019;52(7):1761–1770. doi:10.1021/acs.accounts.9b00109
   PubMed Web of Science ®Google Scholar
• Aryani A, Denecke B. Exosomes as a nanodelivery system: a key to the future of neuromedicine? Mol Neurobiol. 2016;53(2):818–834. doi:10.1007/s12035-014-9054-5
   PubMed Web of Science ®Google Scholar
• Tran HLP, Duan W, Lee B-J, Tran TDT. Current perspectives on delivery systems using extracellular vesicles in neurological disease. Curr Pharm Des. 2020;26(7):764–771. doi:10.2174/1381612826666200102125847
   PubMed Web of Science ®Google Scholar
• Hallal S, Ebrahimkhani S, Shivalingam B, Graeber MB, Kaufman KL, Buckland ME. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring. Brain Tumor Pathol. 2019;36(2):29–39. doi:10.1007/s10014-019-00335-0
   PubMed Web of Science ®Google Scholar
• Amaral M, Cruz N, Rosa A, et al. An update of advanced nanoplatforms for glioblastoma multiforme management. EXCLI J. 2021;20:1544–1570. doi:10.17179/excli2021-4393
   PubMed Web of Science ®Google Scholar
• d’Angelo M, Castelli V, Benedetti E, et al. Theranostic nanomedicine for malignant gliomas. Front Bioeng Biotechnol. 2019;7:325. doi:10.3389/fbioe.2019.00325
   PubMed Web of Science ®Google Scholar
• Imran M, Jha LA, Hasan N, et al. “Nanodecoys” - future of drug delivery by encapsulating nanoparticles in natural cell membranes. Int J Pharm. 2022;621:121790. doi:10.1016/j.ijpharm.2022.121790
   PubMedGoogle Scholar
• Qiao B, Song X, Zhang N, et al. Artificial nano-red blood cells nanoplatform with lysosomal escape capability for ultrasound imaging-guided on-demand pain management. Acta Biomater. 2023;158:798–810. doi:10.1016/j.actbio.2023.01.004
   PubMed Web of Science ®Google Scholar
• Lopes J, Lopes D, Pereira-Silva M, et al. Macrophage cell membrane-cloaked nanoplatforms for biomedical applications. Small Methods. 2022;6(8):e2200289. doi:10.1002/smtd.202200289
   PubMed Web of Science ®Google Scholar
• Pan W-L, Tan Y, Meng W, et al. Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework. Biomaterials. 2022;283:121449. doi:10.1016/j.biomaterials.2022.121449
   PubMed Web of Science ®Google Scholar
• Khosravi N, Pishavar E, Baradaran B, Oroojalian F, Mokhtarzadeh A. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: a promising biomimetic nanoplatforms for cancer theranostics. J Control Release. 2022;348:706–722. doi:10.1016/j.jconrel.2022.06.026
   PubMed Web of Science ®Google Scholar
• Wei X, Zhang G, Ran D, et al. T-cell-mimicking nanoparticles can neutralize HIV infectivity. Adv Mater. 2018;30(45):e1802233. doi:10.1002/adma.201802233
   PubMed Web of Science ®Google Scholar
• Jiang Q, Liu Y, Guo R, et al. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors. Biomaterials. 2019;192:292–308. doi:10.1016/j.biomaterials.2018.11.021
   PubMed Web of Science ®Google Scholar
• Wang D, Dong H, Li M, et al. Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano. 2018;12(6):5241–5252. doi:10.1021/acsnano.7b08355
   PubMed Web of Science ®Google Scholar
• Dad HA, Gu T-W, Zhu A-Q, Huang L-Q, Peng L-H. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther. 2021;29(1):13–31. doi:10.1016/j.ymthe.2020.11.030
   PubMed Web of Science ®Google Scholar
• Tauro BJ, Greening DW, Mathias RA, et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012;56(2):293–304. doi:10.1016/j.ymeth.2012.01.002
   PubMed Web of Science ®Google Scholar
• Zhang L, Feng Q, Wang J, Sun J, Shi X, Jiang X. Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents delivery. Angew Chem Int Ed Engl. 2015;54(13):3952–3956. doi:10.1002/anie.201500096
   PubMed Web of Science ®Google Scholar
• Yang S, Guo F, Kiraly B, et al. Microfluidic synthesis of multifunctional janus particles for biomedical applications. Lab Chip. 2012;12(12):2097–2102. doi:10.1039/c2lc90046g
   PubMed Web of Science ®Google Scholar
• Liu C, Guo J, Tian F, et al. Field-free isolation of exosomes from extracellular vesicles by microfluidic viscoelastic flows. ACS Nano. 2017;11(7):6968–6976. doi:10.1021/acsnano.7b02277
   PubMed Web of Science ®Google Scholar
• Lee K, Shao H, Weissleder R, Lee H. Acoustic purification of extracellular microvesicles. ACS Nano. 2015;9(3):2321–2327. doi:10.1021/nn506538f
   PubMed Web of Science ®Google Scholar
• Wu Z, Zhang H, Yan J, Wei Y, Su J. Engineered biomembrane-derived nanoparticles for nanoscale theranostics. Theranostics. 2023;13(1):20–39. doi:10.7150/thno.76894
   PubMed Web of Science ®Google Scholar
• Silva AKA, Di Corato R, Pellegrino T, et al. Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials. Nanoscale. 2013;5(23):11374–11384. doi:10.1039/c3nr01541f
   PubMed Web of Science ®Google Scholar
• Ye S, Wang F, Fan Z, et al. Light/pH-triggered biomimetic red blood cell membranes camouflaged small molecular drug assemblies for imaging-guided combinational chemo-photothermal therapy. ACS Appl Mater Interfaces. 2019;11(17):15262–15275. doi:10.1021/acsami.9b00897
   PubMed Web of Science ®Google Scholar
• Zhu L, Zhong Y, Wu S, et al. Cell membrane camouflaged biomimetic nanoparticles: focusing on tumor theranostics. Mater Today Bio. 2022;14:100228. doi:10.1016/j.mtbio.2022.100228
   PubMedGoogle Scholar
• Wu T, Liu Y, Cao Y, Liu Z. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma. Adv Mater. 2022;34(15):e2110364. doi:10.1002/adma.202110364
   PubMed Web of Science ®Google Scholar
• Rao L, Cai B, L-L B, et al. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano. 2017;11(4):3496–3505. doi:10.1021/acsnano.7b00133
   PubMed Web of Science ®Google Scholar
• Zalba S, Ten Hagen TLM. Cell membrane modulation as adjuvant in cancer therapy. Cancer Treat Rev. 2017;52:48–57. doi:10.1016/j.ctrv.2016.10.008
   PubMed Web of Science ®Google Scholar
• Kainuma R, Motohashi Y, Nishihara T, Kurihara R, Tanabe K. Modulation of cell membrane functionalization with aggregates of oligodeoxynucleotides containing alkyl chain-modified uridines. Org Biomol Chem. 2020;18(28):5406–5413. doi:10.1039/d0ob00943a
   PubMed Web of Science ®Google Scholar
• Escribá PV, Busquets X, Inokuchi J-I, et al. Membrane lipid therapy: modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment. Prog Lipid Res. 2015;59:38–53. doi:10.1016/j.plipres.2015.04.003
   PubMed Web of Science ®Google Scholar
• Sletten EM, Bertozzi CR. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Engl. 2009;48(38):6974–6998. doi:10.1002/anie.200900942
   PubMed Web of Science ®Google Scholar
• Levy O, Zhao W, Mortensen LJ, et al. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood. 2013;122(14):e23–e32. doi:10.1182/blood-2013-04-495119
   PubMed Web of Science ®Google Scholar
• Lao Y-H, Li M, Gao MA, et al. HPV oncogene manipulation using nonvirally delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute. Adv Sci. 2018;5(7):1700540. doi:10.1002/advs.201700540
   Web of Science ®Google Scholar
• Vats M, Mishra SK, Baghini MS, Chauhan DS, Srivastava R, De A. Near infrared fluorescence imaging in nano-therapeutics and photo-thermal evaluation. Int J Mol Sci. 2017;18(5):924. doi:10.3390/ijms18050924
   PubMed Web of Science ®Google Scholar
• Young RM, Jamshidi A, Davis G, Sherman JH. Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med. 2015;3(9):121. doi:10.3978/j.issn.2305-5839.2015.05.10
   PubMed Web of Science ®Google Scholar
• Reichel D, Sagong B, Teh J, et al. Near infrared fluorescent nanoplatform for targeted intraoperative resection and chemotherapeutic treatment of glioblastoma. ACS Nano. 2020;14(7):8392–8408. doi:10.1021/acsnano.0c02509
   PubMed Web of Science ®Google Scholar
• Mahmood U, Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther. 2003;2(5):489–496.
   PubMed Web of Science ®Google Scholar
• Ferraro N, Barbarite E, Albert TR, et al. The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review. Neurosurg Rev. 2016;39(4):545–555. doi:10.1007/s10143-015-0695-2
   PubMed Web of Science ®Google Scholar
• Kortmann R-D, Jeremic B, Weller M, Plasswilm L, Bamberg M. Radiochemotherapy of malignant glioma in adults. Clinical experiences. Strahlenther Onkol. 2003;179(4):219–232. doi:10.1007/s00066-003-1027-y
   PubMed Web of Science ®Google Scholar
• Ma J, Dai L, Yu J, et al. Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials. 2023;295:122026. doi:10.1016/j.biomaterials.2023.122026
   PubMed Web of Science ®Google Scholar
• Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17(11):657–674. doi:10.1038/s41571-020-0410-2
   PubMed Web of Science ®Google Scholar
• Jaque D, Martínez Maestro L, Del Rosal B, et al. Nanoparticles for photothermal therapies. Nanoscale. 2014;6(16):9494–9530. doi:10.1039/c4nr00708e
   PubMed Web of Science ®Google Scholar
• Son S, Kim JH, Wang X, et al. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev. 2020;49(11):3244–3261. doi:10.1039/c9cs00648f
   PubMed Web of Science ®Google Scholar
• Pan X, Wang H, Wang S, et al. Sonodynamic therapy (SDT): a novel strategy for cancer nanotheranostics. Sci China Life Sci. 2018;61(4):415–426. doi:10.1007/s11427-017-9262-x
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X, Yang H, et al. Advanced biotechnology-assisted precise sonodynamic therapy. Chem Soc Rev. 2021;50(20):11227–11248. doi:10.1039/d1cs00403d
   PubMed Web of Science ®Google Scholar
• Dong -Z-Z, Yang C, Wang Z, Zhong Z, Wong M-S, H-w L. Tumor microenvironment-responsive Zn/Cu nanoparticles for enhanced chemodynamic therapy. Smart Mater Struct. 2023;4:286–293. doi:10.1016/j.smaim.2022.11.002
   Google Scholar
• Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807–821. doi:10.1038/s41423-020-0488-6
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25:267–296. doi:10.1146/annurev.immunol.25.022106.141609
   PubMed Web of Science ®Google Scholar
• Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175–196. doi:10.1038/s41573-018-0006-z
   PubMed Web of Science ®Google Scholar
• Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70(2):86–104. doi:10.3322/caac.21596
   PubMed Web of Science ®Google Scholar
• Tobias A, Ahmed A, Moon K-S, Lesniak MS. The art of gene therapy for glioma: a review of the challenging road to the bedside. J Neurol Neurosurg Psychiatry. 2013;84(2):213–222. doi:10.1136/jnnp-2012-302946
   PubMed Web of Science ®Google Scholar
• Han S, Lee Y, Lee M. Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to glioblastoma. J Control Release. 2021;338:22–32. doi:10.1016/j.jconrel.2021.08.021
   PubMed Web of Science ®Google Scholar
• Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013;123(9):3685–3692. doi:10.1172/JCI69741
   PubMed Web of Science ®Google Scholar
• Dymek M, Sikora E. Liposomes as biocompatible and smart delivery systems - the current state. Adv Colloid Interface Sci. 2022;309:102757. doi:10.1016/j.cis.2022.102757
   PubMed Web of Science ®Google Scholar
• Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601:120571. doi:10.1016/j.ijpharm.2021.120571
   PubMed Web of Science ®Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;975. doi:10.2147/ijn.s68861
   PubMed Web of Science ®Google Scholar
• Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev. 2015;115(19):10938–10966. doi:10.1021/acs.chemrev.5b00046
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine. 2006;1(3):297–315.
   PubMed Web of Science ®Google Scholar
• Mojarad-Jabali S, Farshbaf M, Walker PR, et al. An update on actively targeted liposomes in advanced drug delivery to glioma. Int J Pharm. 2021;602:120645. doi:10.1016/j.ijpharm.2021.120645
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ren W, Zhong T, et al. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. J Control Release. 2016;222:56–66. doi:10.1016/j.jconrel.2015.12.006
   PubMed Web of Science ®Google Scholar
• Jia Y, Wang X, Hu D, et al. Phototheranostics: active targeting of orthotopic glioma using biomimetic proteolipid nanoparticles. ACS Nano. 2019;13(1):386–398. doi:10.1021/acsnano.8b06556
   PubMed Web of Science ®Google Scholar
• Wei L, Guo X-Y, Yang T, Yu M-Z, Chen D-W, Wang J-C. Brain tumor-targeted therapy by systemic delivery of siRNA with transferrin receptor-mediated core-shell nanoparticles. Int J Pharm. 2016;510(1):394–405. doi:10.1016/j.ijpharm.2016.06.127
   PubMed Web of Science ®Google Scholar
• R-j J, Zeng F, Liu L, et al. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma. Int J Nanomedicine. 2016;11:1131–1146. doi:10.2147/IJN.S94467
   PubMed Web of Science ®Google Scholar
• Weyland M, Griveau A, Bejaud J, Benoit JP, Coursaget P, Garcion E. Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cells. Int J Pharm. 2013;454(2):756–764. doi:10.1016/j.ijpharm.2013.06.013
   PubMedGoogle Scholar
• Ismail M, Yang W, Li Y, et al. Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma. Biomaterials. 2022;287:121608. doi:10.1016/j.biomaterials.2022.121608
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang X, Huang J, et al. Bio-fabricated nanodrugs with chemo-immunotherapy to inhibit glioma proliferation and recurrence. J Control Release. 2023;354:572–587. doi:10.1016/j.jconrel.2023.01.023
   PubMed Web of Science ®Google Scholar
• Tian W, Ying X, Du J, et al. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. Eur J Pharm Sci. 2010;41(2):232–243. doi:10.1016/j.ejps.2010.06.008
   PubMed Web of Science ®Google Scholar
• Li J, Zeng H, You Y, et al. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin. J Nanobiotechnology. 2021;19(1):289. doi:10.1186/s12951-021-01048-3
   PubMed Web of Science ®Google Scholar
• Ying X, Wen H, Lu W-L, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release. 2010;141(2):183–192. doi:10.1016/j.jconrel.2009.09.020
   PubMed Web of Science ®Google Scholar
• Mu L-M, Bu Y-Z, Liu L, et al. Lipid vesicles containing transferrin receptor binding peptide TfR-T and octa-arginine conjugate stearyl-R efficiently treat brain glioma along with glioma stem cells. Sci Rep. 2017;7(1):3487. doi:10.1038/s41598-017-03805-7
   PubMedGoogle Scholar
• Yang -Z-Z, J-q L, Wang -Z-Z, Dong D-W, X-r Q. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Biomaterials. 2014;35(19):5226–5239. doi:10.1016/j.biomaterials.2014.03.017
   PubMed Web of Science ®Google Scholar
• Wu H, Liu Y, Chen L, et al. Combined biomimetic MOF-RVG15 nanoformulation efficient over BBB for effective anti-glioblastoma in mice model. Int J Nanomedicine. 2022;17:6377–6398. doi:10.2147/IJN.S387715
   PubMed Web of Science ®Google Scholar
• Dube T, Kompella UB, Panda JJ. Near infrared triggered chemo-PTT-PDT effect mediated by glioma directed twin functional-chimeric peptide-decorated gold nanoroses. J Photochem Photobiol B. 2022;228:112407. doi:10.1016/j.jphotobiol.2022.112407
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Kwon GS, Okano T, Sakurai Y, Seto T, Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconjug Chem. 1992;3(4):295–301. doi:10.1021/bc00016a007
   PubMed Web of Science ®Google Scholar
• Miyata K, Christie RJ, Kataoka K. Polymeric micelles for nano-scale drug delivery. React Funct Polym. 2011;71(3):227–234. doi:10.1016/j.reactfunctpolym.2010.10.009
   Web of Science ®Google Scholar
• Wanjale MV, Kumar GSV. Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma. Expert Opin Drug Deliv. 2017;14(6):811–824. doi:10.1080/17425247.2017.1242574
   PubMed Web of Science ®Google Scholar
• Ran D, Mao J, Shen Q, et al. GRP78 enabled micelle-based glioma targeted drug delivery. J Control Release. 2017;255:120–131. doi:10.1016/j.jconrel.2017.03.037
   PubMed Web of Science ®Google Scholar
• Ran D, Zhou J, Chai Z, et al. All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide. Theranostics. 2020;10(9):4073–4087. doi:10.7150/thno.41382
   PubMed Web of Science ®Google Scholar
• Ran D, Mao J, Zhan C, et al. d-retroenantiomer of quorum-sensing peptide-modified polymeric micelles for brain tumor-targeted drug delivery. ACS Appl Mater Interfaces. 2017;9(31):25672–25682. doi:10.1021/acsami.7b03518
   PubMed Web of Science ®Google Scholar
• Ruan H, Chai Z, Shen Q, et al. A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery. J Control Release. 2018;279:306–315. doi:10.1016/j.jconrel.2018.04.035
   PubMed Web of Science ®Google Scholar
• Yang Z, Du Y, Sun Q, et al. Albumin-based nanotheranostic probe with hypoxia alleviating potentiates synchronous multimodal imaging and phototherapy for glioma. ACS Nano. 2020;14(5):6191–6212. doi:10.1021/acsnano.0c02249
   PubMed Web of Science ®Google Scholar
• Lin T, Zhao P, Jiang Y, et al. Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy. ACS Nano. 2016;10(11). doi:10.1021/acsnano.6b04268
   Web of Science ®Google Scholar
• Zhu S, Sun F, Zhao P, et al. Brain-targeting biomimetic nanoparticles for codelivery of celastrol and LY2157299 for reversing glioma immunosuppression. Int J Pharm. 2022;619:121709. doi:10.1016/j.ijpharm.2022.121709
   PubMedGoogle Scholar
• Zhao P, Wang Y, Kang X, et al. Dual-targeting biomimetic delivery for anti-glioma activity remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy. Chem Sci. 2018;9(10):2674–2689. doi:10.1039/c7sc04853j
   PubMed Web of Science ®Google Scholar
• Mo X, Zheng Z, He Y, et al. Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide. J Control Release. 2018;287:12–23. doi:10.1016/j.jconrel.2018.08.012
   PubMed Web of Science ®Google Scholar
• Wang B, Tang M, Yuan Z, et al. Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy. Bioact Mater. 2022;16:232–248. doi:10.1016/j.bioactmat.2022.02.026
   PubMed Web of Science ®Google Scholar
• Jia W, Tian H, Jiang J, et al. Brain-targeted HFn-Cu-REGO nanoplatform for site-specific delivery and manipulation of autophagy and cuproptosis in glioblastoma. Small. 2023;19(2):e2205354. doi:10.1002/smll.202205354
   PubMed Web of Science ®Google Scholar
• Geng W, Zou H, Wang H, et al. Dual-triggered biomimetic vehicles enable treatment of glioblastoma through a cancer stem cell therapeutic strategy. Nanoscale. 2021;13(15):7202–7219. doi:10.1039/d0nr08899d
   PubMed Web of Science ®Google Scholar
• Huang J-L, Jiang G, Song Q-X, et al. Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to ras-activated glioblastoma cells via macropinocytosis. Nat Commun. 2017;8:15144. doi:10.1038/ncomms15144
   PubMed Web of Science ®Google Scholar
• Wang R, Wang X, Li J, Di L, Zhou J, Ding Y. Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma. Bioact Mater. 2022;13:286–299. doi:10.1016/j.bioactmat.2021.10.039
   PubMed Web of Science ®Google Scholar
• S-y W, Y-x Y, Zhang Q, et al. Multifunctional protein hybrid nanoplatform for synergetic photodynamic-chemotherapy of malignant carcinoma by homologous targeting combined with oxygen transport. Adv Sci. 2023;10(5):e2203742. doi:10.1002/advs.202203742
   Web of Science ®Google Scholar
• Cao H, Duan L, Zhang Y, Cao J, Zhang K. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct Target Ther. 2021;6(1):426. doi:10.1038/s41392-021-00830-x
   PubMed Web of Science ®Google Scholar
• Gutierrez AM, Frazar EM, Klaus MV X, Paul P, Hilt JZ. Hydrogels and hydrogel nanocomposites: enhancing healthcare through human and environmental treatment. Adv Healthc Mater. 2022;11(7):e2101820. doi:10.1002/adhm.202101820
   PubMed Web of Science ®Google Scholar
• Norouzi M, Nazari B, Miller DW. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov Today. 2016;21(11):1835–1849. doi:10.1016/j.drudis.2016.07.006
   PubMed Web of Science ®Google Scholar
• Zhang A, Liu Y, Qin D, Sun M, Wang T, Chen X. Research status of self-healing hydrogel for wound management: a review. Int J Biol Macromol. 2020;164:2108–2123. doi:10.1016/j.ijbiomac.2020.08.109
   PubMed Web of Science ®Google Scholar
• Yao Q, Lan Q-H, Jiang X, et al. Bioinspired biliverdin/silk fibroin hydrogel for antiglioma photothermal therapy and wound healing. Theranostics. 2020;10(25):11719–11736. doi:10.7150/thno.47682
   PubMed Web of Science ®Google Scholar
• Melero I, Castanon E, Alvarez M, Champiat S, Marabelle A. Intratumoural administration and tumour tissue targeting of cancer immunotherapies. Nat Rev Clin Oncol. 2021;18(9):558–576. doi:10.1038/s41571-021-00507-y
   PubMed Web of Science ®Google Scholar
• Mirshafiee V, Mahmoudi M, Lou K, Cheng J, Kraft ML. Protein corona significantly reduces active targeting yield. Chem Comm. 2013;49(25):2557. doi:10.1039/c3cc37307j
   PubMed Web of Science ®Google Scholar
• Salvati A, Pitek AS, Monopoli MP, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol. 2013;8(2):137–143. doi:10.1038/nnano.2012.237
   PubMed Web of Science ®Google Scholar
• Yang W, Guo W, Chang J, Zhang B. Protein/peptide-templated biomimetic synthesis of inorganic nanoparticles for biomedical applications. J Mater Chem B. 2017;5(3):401–417. doi:10.1039/c6tb02308h
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Lin X, He Q. Cell membrane-camouflaged colloid motors for biomedical applications. Adv Ther. 2018;1(5):1800056. doi:10.1002/adtp.201800056
   Google Scholar
• Ou J, Liu K, Jiang J, et al. Micro-/nanomotors toward biomedical applications: the recent progress in biocompatibility. Small. 2020;16(27):e1906184. doi:10.1002/smll.201906184
   PubMed Web of Science ®Google Scholar
• Gao W, Wang J. Synthetic micro/nanomotors in drug delivery. Nanoscale. 2014;6(18):10486–10494. doi:10.1039/c4nr03124e
   PubMed Web of Science ®Google Scholar
• Wang J, Dong R, Wu H, Cai Y, Ren B. A review on artificial micro/nanomotors for cancer-targeted delivery, diagnosis, and therapy. Nanomicro Lett. 2020;12(1):1–9.
   Web of Science ®Google Scholar
• Zhang X, Yang T, Wu Y, He Q. Research progress in the application of colloidal motors for precision medicine. Nanoscale. 2022;14(35):12547–12559. doi:10.1039/d2nr03963j
   PubMed Web of Science ®Google Scholar
• Kumthekar P, Ko CH, Paunesku T, et al. A first-in-human Phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. Sci Transl Med. 2021;13(584). doi:10.1126/scitranslmed.abb3945
   PubMed Web of Science ®Google Scholar